INSIDER ACCESS: DIA Member Exclusive

Watch, read, listen, learn: Interpretation of New Pharmacovigilance Regulations: Key Insights includes interactive transcript and downloadable audio!
Start Exploring
DIA Deep Dive: Pharmacovigilance and Safety

With drug for Parkinson’s approved in US, company reorganizes to create PV and quality divisions that report directly to CEO. What else is new in pharmacovigilance?
Start Exploring
CEE Countries Prepare for New Clinical Trial Regulation

Critical for these Member States to define clinical trials designed to provide patient access to innovative treatments under new CTR
Read Now
PODCAST: How Do You Put Your Disease on the Agenda?

Rare disease research is more than asking science for answers. It’s seeking social justice for these patients.
Listen Now
DIA NOW delivering Always-On Insights

Making the intersection of healthcare accessible anytime, anywhere, across any device.
Start Exploring
How Does DIA Membership Benefit You?
Connect with global influencers, and uncover ways to deliver impactful change
Access new knowledge that keeps you on the cutting-edge of healthcare conversations
Advance career development goals through best-in-class learning programs
Open doors to new pathways towards leadership growth
Expand your network to include global peers who support one another in real time
Christi Marsh
"DIA quickly became a valuable place not only for education, but for networking and leadership growth as well. Today, it just feels like a large professional family that I really could not do without."
Christi Marsh
Director, Medical Affairs, Medical Information & Scientific Communication, HEMA Biologics, LLC
Atsushi Tsukamoto
“DIA is a very unique opportunity for me to both express my opinions and listen to the opinions of my colleagues across regulatory, industry and academia. We all get together to discuss important topics very openly and freely. Plus, it’s fun!"
Dr. Atsushi Tsukamoto
Vice President, New Drug Regulatory Affairs Department, Development Function, R&D Division, Daiichi Sankyo Co. Ltd.
Christi Marsh
"DIA quickly became a valuable place not only for education, but for networking and leadership growth as well. Today, it just feels like a large professional family that I really could not do without."
Christi Marsh
Director, Medical Affairs, Medical Information & Scientific Communication, HEMA Biologics, LLC
Atsushi Tsukamoto
“DIA is a very unique opportunity for me to both express my opinions and listen to the opinions of my colleagues across regulatory, industry and academia. We all get together to discuss important topics very openly and freely. Plus, it’s fun!"
Dr. Atsushi Tsukamoto
Vice President, New Drug Regulatory Affairs Department, Development Function, R&D Division, Daiichi Sankyo Co. Ltd.
Global Forum, DIA's Digital Magazine
Uncover expert insights through global and regional coverage of the discovery, development, regulation, surveillance, and marketing of healthcare products, including interviews with thought leaders and topical summaries from educational events.
DIA's Podcast Channel
Get inside the minds of life science leaders as they share perspectives on current issues in healthcare product development, and the potential paths that lie ahead.